These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13684848)

  • 1. [Treatment of severe forms of myasthenia with intravenous ACTH].
    de ASSIS J
    Arq Neuropsiquiatr; 1960 Dec; 18():359-82. PubMed ID: 13684848
    [No Abstract]   [Full Text] [Related]  

  • 2. The place of corticotropin in the treatment of myasthenia gravis.
    FREYDBERG LD
    Ann Intern Med; 1960 Apr; 52():806-18. PubMed ID: 13824951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of severe cases of myasthenia; action of ACTH and cortisone, considerations apropos of three cases].
    LAMARTINE DE ASSIS J
    Arq Neuropsiquiatr; 1956 Mar; 14(1):28-36. PubMed ID: 13315056
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of adrenocorticotrophic hormone in the treatment of myasthenia gravis.
    SHAPIRO SK
    Minn Med; 1951 Dec; 34(12):1160-4. PubMed ID: 14890619
    [No Abstract]   [Full Text] [Related]  

  • 5. Remission in a case of myasthenia gravis following the use of acth.
    DITTLER EL
    N Y State J Med; 1952 Jun; 52(12):1565. PubMed ID: 14941381
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis; some observations on the effects of various therapeutic agents, including thymectomy and ACTH in a nine year old child.
    RITTER JA; EPSTEIN N
    Am J Med Sci; 1950 Jul; 220(1):66-73. PubMed ID: 15425517
    [No Abstract]   [Full Text] [Related]  

  • 7. Corticotropin therapy and thymectomy in management of severe, generalized myasthenia gravis.
    Namba T; Shapiro MS; Brunner NG; Grob D
    Trans Am Neurol Assoc; 1970; 95():295-7. PubMed ID: 4328100
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated corticotroph insufficiency associated to myasthenia gravis.
    Corcuff JB; Lafranque P; Henry P; Roger P
    J Endocrinol Invest; 1997 Dec; 20(11):669-71. PubMed ID: 9492106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin therapy and thymectomy in management of myasthenia gravis.
    Shapiro MS; Namba T; Grob D
    Arch Neurol; 1971 Jan; 24(1):65-71. PubMed ID: 4322008
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostigmine-induced muscle weakness in myasthenia gravis patients.
    ROWLAND LP; KORENGOLD MC; JAFFE IA; BERG L; SHY GM
    Neurology; 1955 Feb; 5(2):89-99. PubMed ID: 13235984
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of myasthenia].
    DJINDJIAN R
    Concours Med; 1952 Nov; 74(48):4051-2. PubMed ID: 13020322
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration.
    GROB D; HARVEY AM
    Bull Johns Hopkins Hosp; 1952 Aug; 91(2):124-36. PubMed ID: 14944967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present status of the treatment of myasthenia].
    FURTADO D
    G Psichiatr Neuropatol; 1951; 79(2):135-53. PubMed ID: 14887945
    [No Abstract]   [Full Text] [Related]  

  • 14. [The modern treatment of myasthenia. (Apropos of a personal case)].
    CREMIEUX A; BOUDOURESQUES J; BILLE J
    Mars Med; 1962; 99():547-50. PubMed ID: 13882122
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular response to corticotropin in myasthenia gravis.
    Cape CA
    Arch Ophthalmol; 1973 Oct; 90(4):292-3. PubMed ID: 4355713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of myasthenia].
    BAUER H; SCHMID O
    Dtsch Z Nervenheilkd; 1953; 169(6):427-37. PubMed ID: 13083321
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary note on the use of a spirolactone in the treatment of myasthenia].
    JEUNE M; VINCENT P; HUMBERT G; LEVRAT R
    Lyon Med; 1962 May; 94():1343-50. PubMed ID: 14451753
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in therapy of myasthenia with tetraisopropyl pyrophosphate (myastenol)].
    MOLINA ; GOTZE W
    Arztl Wochensch; 1952 Dec; 7(50):1186-7. PubMed ID: 13016389
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of Erb-Goldflam myasthenia. Trial of a new anti-myasthenic product].
    SUTTER ; JORDA ; LEBASCLE
    Rev Otoneuroophtalmol; 1953 Apr; 25(3):169-72. PubMed ID: 13075453
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sino-carotid enervation in the surgical treatment of myasthenia. Apropos of 35 personal observations].
    LEGER L; BANZET P
    Presse Med (1893); 1961 Jul; 69():1479-81. PubMed ID: 13760360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.